Pediatrix Medical Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 2yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Pediatrix Medical Group (NYSE:MD) Is Doing The Right Things To Multiply Its Share Price
Jan 05
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Dec 15Pediatrix Medical Group's (NYSE:MD) Earnings Seem To Be Promising
Nov 10Risks To Shareholder Returns Are Elevated At These Prices For Pediatrix Medical Group, Inc. (NYSE:MD)
Jul 31
Expanding NICU And Maternal Services Will Fuel US Healthcare Growth
Expanding service offerings, improved payer mix, and strategic acquisitions are driving revenue growth, earnings stability, and reduced earnings volatility.Is Pediatrix Medical Group (NYSE:MD) Using Too Much Debt?
May 22Insufficient Growth At Pediatrix Medical Group, Inc. (NYSE:MD) Hampers Share Price
May 01These 4 Measures Indicate That Pediatrix Medical Group (NYSE:MD) Is Using Debt Extensively
Feb 18Returns At Pediatrix Medical Group (NYSE:MD) Are On The Way Up
Jan 28Pediatrix Medical Group: The Business Is Turning
Nov 18Pediatrix Medical Group, Inc. (NYSE:MD) Shares Fly 27% But Investors Aren't Buying For Growth
Nov 06Here's Why Pediatrix Medical Group (NYSE:MD) Has A Meaningful Debt Burden
Oct 19We Like These Underlying Return On Capital Trends At Pediatrix Medical Group (NYSE:MD)
Sep 28Improved Revenues Required Before Pediatrix Medical Group, Inc. (NYSE:MD) Stock's 32% Jump Looks Justified
Aug 07Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15CEO
Pediatrix Medical Group has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive VP | 1.3yrs | US$1.34m | 0.091% $ 1.7m | |
| Chief Administrative Officer | 3.3yrs | US$2.39m | 0.22% $ 4.1m | |
| Executive Vice President of National Operations | no data | no data | no data | |
| Executive VP and Chief Investment & Strategy Officer | 1yr | no data | 0.097% $ 1.8m | |
| Senior VP & Chief Accounting Officer | 9.7yrs | US$1.43m | no data | |
| Senior VP & Chief Information Officer | 4yrs | no data | no data | |
| Senior Vice President of People Services | 1.3yrs | no data | no data | |
| President of West Division | 1yr | no data | no data | |
| President of South Central Division | no data | no data | no data | |
| Chief Medical Officer of South Central Division | no data | no data | no data | |
| Senior Vice President of Medical Administrative Services | 3.7yrs | no data | no data | |
| President of East Coast Division | 2yrs | no data | no data |
Experienced Management: MD's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Lead Independent Director | 5.5yrs | US$280.00k | 0.095% $ 1.7m | |
| Independent Director | 5.5yrs | US$252.50k | 0.078% $ 1.4m | |
| Independent Director | 2.7yrs | US$230.00k | 0.048% $ 882.6k | |
| Independent Director | 5.5yrs | US$230.00k | 0.078% $ 1.4m | |
| Independent Director | 5.5yrs | US$245.00k | 0.056% $ 1.0m | |
| Independent Director | less than a year | no data | 0.012% $ 211.6k | |
| Board Observer | 5.5yrs | no data | no data | |
| Independent Director | 6.7yrs | US$242.50k | 0.070% $ 1.3m | |
| Independent Director | 3.7yrs | US$230.00k | 0.015% $ 270.4k |
Experienced Board: MD's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/21 16:25 |
| End of Day Share Price | 2026/01/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pediatrix Medical Group, Inc. is covered by 28 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Matthew Gillmor | Baird |
| Matthew Borsch | BMO Capital Markets Equity Research |